Cassidy Bio
Driving Genome Editing Therapeutics Forward
StartupCassidy Bio is a Tel Aviv-Yafo-based startup in the Health Tech & Life Sciences sector, established in 2024. Driving Genome Editing Therapeutics Forward. The company has raised a total of $8M across 1 funding round, currently at the Seed stage. Cassidy Bio was founded by Yaniv Shmueli. Key investors include AION Labs, 10D, UnBox Ventures, among 5 total investors. The company has 11-50 employees. Core technologies: Biologicals, Genes.
With $8M in total funding, Cassidy Bio is a Seed-stage company operating in Health Tech & Life Sciences. The company follows a B2B business model. Product stage: R&D.
- StageSeed
- ProductR&D
- ModelB2B
- Employees11-50
- HQTel Aviv-Yafo
- DistrictCenter District
- Last Round$8M
- AION Labs
- 10D
- UnBox Ventures
5 investors total
Yaniv ShmueliCo-founder & CTO
What does Cassidy Bio do?
This company is a known business entity but lacks sufficient data to support a standard Finder profile.
How much funding has Cassidy Bio raised?
Cassidy Bio has raised $8M in total funding across 1 rounds. The company is currently at the Seed stage. Key investors include AION Labs, 10D, UnBox Ventures.
Who founded Cassidy Bio?
Cassidy Bio was founded in 2024 by Yaniv Shmueli (Co-founder & CTO).
What sector is Cassidy Bio in?
Cassidy Bio operates in Health Tech & Life Sciences, Pharma & Medical Biotechnology, Drugs Discovery & Development, with core technologies in Biologicals, Genes. Target customers: Healthcare & Life Sciences, Life Sciences, Pharmaceuticals, Biotechnology.
Where is Cassidy Bio located?
Cassidy Bio is based in Tel Aviv-Yafo, Israel, Center District.